微创脑科学：Artemis Dream支架系统进入NMPA创新绿色通道

南方财经网07-30

微创脑科学（02172.HK）发布自愿公告，公司附属子公司微创神通医疗科技（上海）有限公司研发的ArtemisDream®娇娟自膨式颅内雷帕霉素洗脱支架系统通过国家药品监督管理局（NMPA）创新医疗器械特别审查申请，正式进入特别审查程序（“绿色通道”）。截至目前，集团已有7款产品纳入NMPA创新医疗器械特别审查。该产品为国内首款靶向药物释放的自膨式颅内动脉支架，采用自膨式结构设计，兼顾力学支撑性与...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2655765848?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-07-30 08:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655765848","market":"hk","top_or_hot":-1,"title":"微创脑科学：Artemis Dream支架系统进入NMPA创新绿色通道","media":"南方财经网","content":"<div>\n<p>微创脑科学（02172.HK）发布自愿公告，公司附属子公司微创神通医疗科技（上海）有限公司研发的ArtemisDream®娇娟自膨式颅内雷帕霉素洗脱支架系统通过国家药品监督管理局（NMPA）创新医疗器械特别审查申请，正式进入特别审查程序（“绿色通道”）。截至目前，集团已有7款产品纳入NMPA创新医疗器械特别审查。该产品为国内首款靶向药物释放的自膨式颅内动脉支架，采用自膨式结构设计，兼顾力学支撑性与...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202607303825784378.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>微创脑科学：Artemis Dream支架系统进入NMPA创新绿色通道</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n微创脑科学：Artemis Dream支架系统进入NMPA创新绿色通道\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-30 08:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202607303825784378.html><strong>南方财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>微创脑科学（02172.HK）发布自愿公告，公司附属子公司微创神通医疗科技（上海）有限公司研发的ArtemisDream®娇娟自膨式颅内雷帕霉素洗脱支架系统通过国家药品监督管理局（NMPA）创新医疗器械特别审查申请，正式进入特别审查程序（“绿色通道”）。截至目前，集团已有7款产品纳入NMPA创新医疗器械特别审查。该产品为国内首款靶向药物释放的自膨式颅内动脉支架，采用自膨式结构设计，兼顾力学支撑性与...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202607303825784378.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://finance.eastmoney.com/a/202607303825784378.html","article_id":"2655765848","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607303825784378.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2655765848","pubTimestamp":1785370200,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"【微创脑科学：Artemis Dream支架系统进入NMPA创新绿色通道】微创脑科学（02172.HK）发布自愿公告，公司附属子公司微创神通医疗科技（上海）有限公司研发的ArtemisDream娇娟自膨式颅内雷帕霉素洗脱支架系统通过国家药品监督管理局（NMPA）创新医疗器械特别审查申请，正式进入特别审查程序（“绿色通道”）。截至目前，集团已有7款产品纳入NMPA创新医疗器械特别审查。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1100":"医疗保健设备","02172":"微创脑科学"},"translate_title":"Minimally Invasive Brain Science: Artemis Dream Stent System Enters NMPA Innovation Green Channel","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02172":1.5},"content_text":"微创脑科学（02172.HK）发布自愿公告，公司附属子公司微创神通医疗科技（上海）有限公司研发的ArtemisDream®娇娟自膨式颅内雷帕霉素洗脱支架系统通过国家药品监督管理局（NMPA）创新医疗器械特别审查申请，正式进入特别审查程序（“绿色通道”）。截至目前，集团已有7款产品纳入NMPA创新医疗器械特别审查。该产品为国内首款靶向药物释放的自膨式颅内动脉支架，采用自膨式结构设计，兼顾力学支撑性与远期预后，并通过“单面刻槽”技术实现仅向血管壁侧定向释药，抑制内膜增生、加速内皮化，有望缩短术后双抗用药周期。本次获批标志着公司在颅内动脉狭窄治疗领域的技术布局获官方再度认可。进入绿色通道将显著缩短注册审评周期，加快产品上市进程，进一步完善集团缺血性脑血管疾病全场景治疗产品矩阵。公司提示，ArtemisDream®最终能否成功商业化存在不确定性。 （文章来源：南方财经网）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2655765848","isCrawlerRequest":true}